SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jinah Choi, Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations, Free Radical Biology and Medicine, 2012, 52, 7, 1135

    CrossRef

  2. 2
    Sara Raimondi, Savino Bruno, Mario U. Mondelli, Patrick Maisonneuve, Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis, Journal of Hepatology, 2009, 50, 6, 1142

    CrossRef

  3. 3
    Emmanuel Thomas, Michael W. Fried, Hepatitis C: Current options for nonresponders to peginterferon and ribavirin, Current Gastroenterology Reports, 2008, 10, 1, 53

    CrossRef

  4. 4
    Scott Seronello, Muhammad Y. Sheikh, Jinah Choi, Redox regulation of hepatitis C in nonalcoholic and alcoholic liver, Free Radical Biology and Medicine, 2007, 43, 6, 869

    CrossRef

  5. 5
    John B Wong, Hepatitis C, PharmacoEconomics, 2006, 24, 7, 661

    CrossRef

  6. 6
    Akito Daiba, Niro Inaba, Satoshi Ando, Naoki Kajiyama, Hiroshi Yatsuhashi, Hiroshi Terasaki, Atsushi Ito, Masanori Ogasawara, Aki Abe, Junichi Yoshioka, Kazuhiro Hayashida, Shuichi Kaneko, Michinori Kohara, Satoru Ito, A low-density cDNA microarray with a unique reference RNA: pattern recognition analysis for IFN efficacy prediction to HCV as a model, Biochemical and Biophysical Research Communications, 2004, 315, 4, 1088

    CrossRef

  7. 7
    Alexander Monto, Alcohol and hepatitis C: Implications for disease progression and treatment, Current Hepatitis Reports, 2004, 3, 3, 105

    CrossRef

  8. 8
    S.-M. Lin, D.-I. Tai, R.-N. Chien, I.-S. Sheen, C.-M. Chu, Y.-F. Liaw, Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B, Journal of Viral Hepatitis, 2004, 11, 4
  9. 9
    William M. Lee, Jules L. Dienstag, Karen L. Lindsay, Anna S. Lok, Herbert L. Bonkovsky, Mitchell L. Shiffman, Gregory T. Everson, Adrian M. Di Bisceglie, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Elizabeth C. Wright, James E. Everhart, Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders, Controlled Clinical Trials, 2004, 25, 5, 472

    CrossRef

  10. 10
    S.-N. Lu, H.-D. Tung, T.-M. Chen, C.-M. Lee, J.-H. Wang, C.-H. Hung, C.-H. Chen, C.-S. Changchien, Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?, Journal of Viral Hepatitis, 2004, 11, 6
  11. 11
    Alexander Monto, Alcohol and hepatitis C: Implications for disease progression and treatment, Current Hepatitis Reports, 2003, 2, 3, 125

    CrossRef

  12. 12
    Renuka Bhattacharya, Margaret C. Shuhart, Hepatitis C and Alcohol, Journal of Clinical Gastroenterology, 2003, 36, 3, 242

    CrossRef

  13. 13
    Yasushi Shiratori, Haruhiko Yoshida, Masao Omata, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  14. 14
    KAZUHIRO UEHARA, TAKAFUMI ICHIDA, SATOSHI SUGAHARA, TORU ISHIKAWA, SATOSHI YAMAGIWA, YUHEI YOSHIDA, MINORU NOMOTO, MASASHI KATOH, HIROSHI SATOH, HISAMI WATANABE, TORU ABO, HITOSHI ASAKURA, Systemic administration of liposome-encapsulated OK-432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-γ-producing hepatic lymphocytes, Journal of Gastroenterology and Hepatology, 2002, 17, 1
  15. 15
    Shuichi Okada, Toshiya Sato, Seiichiro Yamamoto, Adjuvant interferon for hepatocellular carcinoma, Hepatology, 2001, 33, 2
  16. 16
    Toru Ishikawa, Takafumi Ichida, Satoshi Yamagiwa, Satoshi Sugahara, Kazuhiro Uehara, Shogo Okoshi, Hitoshi Asakura, High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis, Journal of Gastroenterology and Hepatology, 2001, 16, 11
  17. 17
    Yasushi Shiratori, Haruhiko Yoshida, Masao Omata, Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention, Expert Review of Anticancer Therapy, 2001, 1, 2, 277

    CrossRef

  18. 18
    Luigi Roffi, Alessandro Redaelli, Guido Colloredo, Eliseo Minola, Carlo Donada, Antonino Picciotto, Paolo Riboli, Paolo Del Poggio, Gianni Rinaldi, Bruno Paris, Giovanni Fornaciari, Massimo Giusti, Renato Marin, Rino Morales, Angelo Sangiovanni, Giovanni Belloni, Massimo Pozzi, Giancarla Poli, Nerina Mascoli, Chiara Corradi, Pietro Pioltelli, Astrid Scalori, Giuseppe Mancia, Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype, European Journal of Gastroenterology & Hepatology, 2001, 13, 5, 501

    CrossRef

  19. 19
    Claudio Zavaglia, Aldo Airoldi, Giovambattista Pinzello, Antiviral Therapy of HBV- and HCV-induced Liver Cirrhosis, Journal of Clinical Gastroenterology, 2000, 30, 3, 234

    CrossRef

  20. 20
    John B Wong, Gary L Davis, Stephen G Pauker, Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C, The American Journal of Medicine, 2000, 108, 5, 366

    CrossRef

  21. 21
    Zhao-You Tang, Hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2000, 15,
  22. 22
    Masao Omata, Yasushi Shiratori, Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C, Journal of Gastroenterology and Hepatology, 2000, 15,
  23. 23
    Shoji Kubo, Shuhei Nishiguchi, Taichi Shuto, Hiromu Tanaka, Tadashi Tsukamoto, Kazuhiro Hirohashi, Takashi Ikebe, Kenichi Wakasa, Tetsuo Kuroki, Hiroaki Kinoshita, Effects of Continuous Hepatitis with Persistent Hepatitis C Viremia on Outcome after Resection of Hepatocellular Carcinoma, Japanese Journal of Cancer Research, 1999, 90, 2
  24. 24
    Arie Regev, Lennox J. Jeffers, Hepatitis C and Alcohol, Alcoholism: Clinical and Experimental Research, 1999, 23, 9
  25. 25
    Geoffrey C Farrell, Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: Flaws in the cure, or a clue to the flaws?, Journal of Gastroenterology and Hepatology, 1999, 14, 9
  26. 26
    Minoru Shibata, Toshio Morizane, Toshikazu Uchida, Tomoyuki Yamagami, Yasushi Onozuka, Masayuki Nakano, Keiji Mitamura, Yukihisa Ueno, Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection, The Lancet, 1998, 351, 9118, 1773

    CrossRef

  27. 27
    YUN-FAN LIAW, Current therapeutic trends in therapy for chronic viral hepatitis, Journal of Gastroenterology and Hepatology, 1997, 12, 9-10